Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and Treatment of Parasellar Lesions.
Neuroendocrinology. 2020;110(9-10):728-739. doi: 10.1159/000506905. Epub 2020 Mar 4.
Neuroendocrinology. 2020.
PMID: 32126547
Free article.
Review.
Except for hormone-producing ectopic pituitary tumors, signs and symptoms of these lesions are usually nonspecific, due to a mass effect on the surrounding anatomical structures (i.e., headache, visual defects), while a clinically relevant impairment of endocrine function (mainly …
Except for hormone-producing ectopic pituitary tumors, signs and symptoms of these lesions are usually nonspecific, due to a mass effect on …
Treatment outcome of metastasis to the pituitary gland: a case series of 21 patients with pathological diagnosis.
Hong S, Atkinson JL, Erickson D, Kizilbash SH, Little JT, Routman DM, Van Gompel JJ.
Hong S, et al.
Neurosurg Focus. 2023 Aug;55(2):E13. doi: 10.3171/2023.5.FOCUS23185.
Neurosurg Focus. 2023.
PMID: 37527679
Patients presented with headache (67% [14/21]), vision problems (86% [18/21]), anterior hypopituitarism (71% [15/21]), and arginine vasopressin deficiency (38% [8/21]). ...Fourteen patients (67%) had adjuvant radiation therapy, and 15 patients (71%) were trea …
Patients presented with headache (67% [14/21]), vision problems (86% [18/21]), anterior hypopituitarism (71% [15/21]), and arg …
Item in Clipboard
Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas.
George LD, Nicolau N, Scanlon MF, Davies JS.
George LD, et al.
Clin Endocrinol (Oxf). 2000 Nov;53(5):595-9. doi: 10.1046/j.1365-2265.2000.01137.x.
Clin Endocrinol (Oxf). 2000.
PMID: 11106920
Patients were assessed before and after cabergoline therapy to assess their growth hormone secretory status, IGF-I levels, cortisol response and change in tumour size. ...Six of the nine (67%) patients recovered a normal growth hormone response (> 10 mU/l) after cabergo …
Patients were assessed before and after cabergoline therapy to assess their growth hormone secretory status, IGF-I levels, cortisol r …
Item in Clipboard
Cite
Cite